Page 137 - CW E-Magazine (5-3-2024)
P. 137

Top Stories                                                                     Pharmaceuticals


 ADVANCED MATERIALS   RAPID DIAGNOSIS
 DCM Shriram announces entry into the business   Bengaluru researchers develop paper-based platform

 of epoxy resins  to detect antibiotic-resistant bacteria


 The Board of directors of DCM  2024-25. Over 80% of ECH produced  products.  The entire portfolio of   A paper-based platform developed  and JNCASR team involves incorporat-  Infusing the hydrogel in a sheet of paper
 Shriram Ltd., at their board meeting  globally is used in the manufacture of  Advanced Materials  products includ-  by researchers at the Indian Institute of  ing biphenyl-4-carboxylic acid (BCA)  as the medium reduced the cost signifi -
 held in New  Delhi on February 27,  epoxy resins.  ing liquid epoxy resins, hardeners,   Science (IISc) and Jawaharlal Nehru  within a supramolecular hydrogel ma-  cantly.  The  instrument  is  fi tted  with
 accorded an in-principle approval for the   solvent cuts, reactive diluents and   Centre for Advanced Scientifi c Research  trix containing terbium cholate (TbCh).  different LEDs that shine UV radiation
 entry of its Chemicals business into   Commenting on the announce-  formulated resins are fi nding increasing   (JNCASR), Bengaluru could help quickly  This hydrogel normally emits green  as  required.  Green  fl uorescence  from
 the domain of Advanced Materials by  ment, Mr. Ajay Shriram, Chairman &  applications in sectors such as wind-  detect  the presence of  antibiotic-resis-  fl uorescence  when  UV  light  is  shined  the enzyme is captured by a built-in
 investing into epoxy resins and value-  Senior Managing Director, and Mr.  blades, EVs, aeronautics, electro-  tant, disease-causing bacteria.  on it. The next step was to fi nd a way  camera, and a dedicated software app
 added products.  Vikram Shriram, Vice Chairman and  nics,  fi re-proofi ng  and  light-weight-  to make the technology  inexpensive.  measures the intensity, which can help
 Managing Director, DCM Shriram,  ing  industries and  India  is  poised  to   Dr. Uday Maitra, Professor at the  Currently used diagnostics instruments  quantify the bacterial load.
 The company is planning to invest  said in a joint statement, “We are  emerge as a market of choice, both for   Department  of Organic  Chemistry,  are costly, which drives up the price for
 Rs. 1,000-crore over the next few years  bullish about the overall prospects of  domestic and global consumption, of   IISc, and collaborators have developed  testing.  The  team  from IISc  tied up with
 to  set  up  a  greenfi eld  state-of-the-art  the Chemicals Business and this entry  such products. DCM Shriram Ltd. will   a rapid diagnosis protocol that uses a   Jayanta  Haldar’s  research  group  from
 epoxy manufacturing plant. It may be  into the  Advanced Materials space.  continue to remain alert to opportu-  luminescent paper-based  platform to   The team  collaborated  with a  JNCASR to check their approach on
 noted that the company’s  epichloro-  We already have some of the key raw  nities arising in the adjacencies of   detect the presence of antibiotic-resis-  Chennai-based company,  Adiuvo Diag-  urine samples.  As the next step, the
 hydrin (ECH) plant in Jhagadia, Gujarat  materials like ECH and caustic in our  its core-chemicals business and look   tant bacteria.  nostics, to design a customised, port-  researchers plan to tie up with hospitals
 is in fi nal stages of completion and is  portfolio, which paves a logical way  to participate whole-heartedly in the   able and miniature imaging device,  to  test  this  technology  with  samples
 expected to be commissioned in Q1 of  forward into the epoxy and value added  India growth story.”  The approach developed by the IISc  named Illuminate Fluorescence Reader.  from patients.

       BANKING ON RESEARCH
 FORM IV
 (See Rule 8)  Bristol Myers Squibb opens innovation hub in Hyderabad
 Statement about ownership and other particulars, about newspaper CHEMICAL WEEKLY
          Bristol Myers Squibb (BMS), the
   1.  Place of Publication   MUMBAI  US-based drug fi rm, opened a new inno-
   2.  Periodicity of its Publication   WEEKLY  vation hub in Hyderabad on February 26.
   3.  Printer’s Name   R. RAGHAVAN  The new facility, which can house over
     Nationality   Indian  1,500 employees, has been built with an
     Address   144-A, Kalpataru Residency, Opp. Cine Planet,  investment of more than $100-mn (nearly
        Kamani Marg, Sion (East), Mumbai 400 022.  Rs. 828-crore). The site will expand the
   4.  Publisher’s Name   R. RAGHAVAN  company’s global drug development
     Nationality   Indian
     Address   144-A, Kalpataru Residency, Opp. Cine Planet,  and information technology and digital
        Kamani Marg, Sion (East), Mumbai 400 022.  capabilities. The launch was attended by
   5.  Editor’s Name   R. RAGHAVAN  the Telangana Minister for Industries &
     Nationality   Indian  Information Technology, Mr. D. Sridhar  global corporate and research and deve-  ping India’s talent in data analytics and
     Address   144-A, Kalpataru Residency, Opp. Cine Planet,  and Chief Executive Offi cer of Bristol  lopment operations and are also tap-  artifi cial intelligence.
        Kamani Marg, Sion (East), Mumbai 400 022.  Myers Squibb, Dr. Christopher Boerner,
   6.  Names and addresses of individuals   1.   R. RAGHAVAN  and other offi cials.  BIOASIA 2024
     who own the newspapers or shareholders      144-A, Kalpataru Residency, Opp. Cine Planet,
     holding more than one per cent of the total capital  Kamani Marg, Sion (East), Mumbai 400 022.  “This investment also enables us to   200 delegates visit Genome Valley in Hyderabad
        2.   VIJAY RAGHAVAN  further diversify our global workforce     Around 200 delegates comprising –  tion centre) and Multitalented Facility
           Flat No. 51, 5th Floor, Khushali, Central Avenue Road,  by adding world-class local talent and  both international delegates and Indian  Neovantage  (Takshashila) to under-
           Chembur, Mumbai 400 071.  strengthening our ability to positively  companies – were taken in for a guided  stand the facility and possible business
   I, R.RAGHAVAN, hereby declare that the particulars given above are true to the best of my knowledge and belief.  impact patients everywhere,” said  tour of the Genome Valley in Hyderabad  prospects. As part of the tour, the dele-
   Date: 05.03.2024          Signature of Publisher:  Dr. Boerner. BMS is among a slew of large  in two groups on the inaugural day  gates were also shown around facilities
       pharma companies setting up their  of BioAsia 2024.  The groups toured  of Bharat Biotech,  Biological  E Ltd.,
           R. RAGHAVAN
       innovation hubs in India to service their  around IKP Knowledge Park (incuba-  and Sai Life Sciences.

 136  Chemical Weekly  March 5, 2024  Chemical Weekly  March 5, 2024                                   137


                                      Contents    Index to Advertisers    Index to Products Advertised
   132   133   134   135   136   137   138   139   140   141   142